Landis+Gyr Group Ltd

Latest Results (04.12.2025):

Landis+Gyr Group Ltd — reporting on Q4 / fiscal year ended March 31, 2025 (Fiscal Year 2024). The company posted net revenue of USD 1,729.3m for the year (down 11.1% year‑over‑year), an adjusted EBITDA of USD 170.9m (down from USD 229.9m) and a net loss attributable to shareholders of USD 150.5m (EPS diluted −5.21). Results were impacted by a USD 111.0m goodwill impairment in EMEA and a USD 64.7m loss on discontinued operations (EV charging business divested in March 2025). Order intake and committed backlog strengthened materially, while free cash flow remained positive at USD 53.7m.

Revenue and profitability

Full‑year net revenue: USD 1,729.3m (FY2023: USD 1,944.2m; −11.1% reported, −10.5% constant currency). Gross profit fell to USD 512.1m and operating income declined to a loss of USD 34.7m (FY2023 operating income USD 152.8m). Adjusted EBITDA was USD 170.9m (9.9% of revenue) vs USD 229.9m (11.8%) last year. Basic/diluted EPS were both negative at −5.21.

Impairment, discontinued operations and one‑offs

The company recorded a USD 111.0m impairment of goodwill allocated to the EMEA reporting unit (citing the strategic exit from the EV charging business among factors). The EV charging business was divested in March 2025 and treated as discontinued operations; the related net loss was USD 64.7m for the year. Management also disclosed restructuring, transformation and warranty normalization adjustments included in adjusted metrics.

Order intake and backlog

Order intake rose strongly to USD 2,613.8m (up 33.3% reported; book‑to‑bill 1.51 for the year). Committed backlog grew to USD 4,630.4m (up 22.9%), with the Americas comprising the bulk of backlog (USD 3,761.9m as of March 31, 2025).

Segment performance

By region: Americas revenue declined to USD 964.6m (from USD 1,131.3m) and adjusted EBITDA for the Americas fell to USD 127.1m (margin ~13.2%). EMEA revenue was USD 606.6m with adjusted EBITDA USD 16.1m (margin ~2.7%). Asia Pacific revenue was USD 158.1m and adjusted EBITDA improved to USD 37.6m (margin ~23.8%), helped by a real estate gain in India and favorable mix.

Cash flow, capex and balance sheet

Cash flow from operations was USD 78.9m; free cash flow (ex‑M&A) USD 53.7m. Cash and equivalents were USD 171.6m. Total debt was USD 344.1m, producing net debt of USD 182.9m. Capital expenditures were USD 31.9m (≈1.8% of revenue). Management states available liquidity and facilities are sufficient for the next 12 months.

Other notable items

R&D was largely steady at USD 172.7m (~10% of sales). Interest expense increased to USD 23.7m (higher credit facility utilization). Income tax expense was USD 10.7m. Management continues transformation and strategic reviews (including a U.S. listing preparation and EMEA review) and notes FY2024 adjusted results exclude certain non‑recurring items such as restructuring and warranty normalization.